and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cara Therapeutics Stock Price (Quote) NASDAQ:CARA
$11.27 ( 7.95% ) Friday, 5th Aug 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $8.13 | $11.31 | Friday, 5th Aug 2022 CARA stock ended at $11.27. This is 7.95% more than the trading day before Thursday, 4th Aug 2022. During the day the stock fluctuated 11.10% from a day low at $10.18 to a day high of $11.31. |
| 90 days | $7.40 | $11.31 | |
| 52 weeks | $7.40 | $18.93 |
Historical Cara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-08-05 | $10.39 | $11.31 | $10.18 | $11.27 | 644 435 |
| 2022-08-04 | $9.40 | $10.44 | $9.40 | $10.44 | 559 880 |
| 2022-08-03 | $8.83 | $9.50 | $8.83 | $9.30 | 404 380 |
| 2022-08-02 | $8.25 | $9.01 | $8.25 | $8.69 | 610 211 |
| 2022-08-01 | $8.86 | $8.86 | $8.13 | $8.24 | 929 567 |
| 2022-07-29 | $9.00 | $9.04 | $8.66 | $8.74 | 389 743 |
| 2022-07-28 | $9.10 | $9.19 | $8.87 | $9.04 | 295 409 |
| 2022-07-27 | $9.17 | $9.36 | $9.02 | $9.14 | 359 639 |
| 2022-07-26 | $9.12 | $9.41 | $8.66 | $9.17 | 744 067 |
| 2022-07-25 | $9.83 | $9.83 | $9.01 | $9.06 | 287 909 |
| 2022-07-22 | $9.97 | $10.21 | $9.66 | $9.71 | 346 644 |
| 2022-07-21 | $9.85 | $10.05 | $9.70 | $9.90 | 531 203 |
| 2022-07-20 | $9.57 | $9.93 | $9.57 | $9.80 | 566 205 |
| 2022-07-19 | $9.20 | $9.78 | $9.20 | $9.63 | 452 578 |
| 2022-07-18 | $9.43 | $9.71 | $9.14 | $9.18 | 384 737 |
| 2022-07-15 | $9.37 | $9.37 | $8.93 | $9.25 | 321 668 |
| 2022-07-14 | $9.58 | $9.65 | $9.09 | $9.20 | 316 991 |
| 2022-07-13 | $9.19 | $9.78 | $9.19 | $9.61 | 266 144 |
| 2022-07-12 | $9.57 | $9.63 | $9.04 | $9.45 | 374 115 |
| 2022-07-11 | $9.61 | $9.76 | $9.30 | $9.61 | 379 464 |
| 2022-07-08 | $9.42 | $9.86 | $9.42 | $9.80 | 324 029 |
| 2022-07-07 | $9.63 | $9.94 | $9.43 | $9.52 | 288 558 |
| 2022-07-06 | $9.20 | $9.66 | $9.14 | $9.59 | 374 390 |
| 2022-07-05 | $8.50 | $9.30 | $8.50 | $9.22 | 531 289 |
| 2022-07-01 | $8.74 | $8.80 | $8.26 | $8.62 | 633 544 |
| 2022-06-30 | $9.72 | $9.79 | $9.05 | $9.13 | 1 153 554 |
| 2022-06-29 | $9.13 | $9.63 | $9.01 | $9.60 | 479 786 |
| 2022-06-28 | $9.73 | $9.73 | $9.25 | $9.26 | 416 560 |
| 2022-06-27 | $9.38 | $9.71 | $9.15 | $9.68 | 400 086 |
| 2022-06-24 | $9.26 | $9.45 | $9.05 | $9.39 | 604 197 |
| 2022-06-23 | $8.70 | $9.16 | $8.70 | $9.12 | 391 823 |
| 2022-06-22 | $8.21 | $8.88 | $8.18 | $8.67 | 408 714 |
| 2022-06-21 | $8.18 | $8.62 | $8.17 | $8.38 | 433 750 |
| 2022-06-17 | $7.84 | $8.28 | $7.80 | $8.04 | 833 328 |
| 2022-06-16 | $7.73 | $7.85 | $7.50 | $7.83 | 336 292 |
| 2022-06-15 | $7.93 | $8.09 | $7.70 | $7.94 | 322 351 |
| 2022-06-14 | $7.85 | $7.85 | $7.43 | $7.80 | 360 788 |
| 2022-06-13 | $7.97 | $8.02 | $7.64 | $7.73 | 444 999 |
| 2022-06-10 | $8.32 | $8.32 | $8.00 | $8.25 | 418 559 |
| 2022-06-09 | $8.73 | $8.75 | $8.40 | $8.50 | 365 617 |
| 2022-06-08 | $8.75 | $9.15 | $8.64 | $8.83 | 521 974 |
| 2022-06-07 | $8.33 | $8.96 | $8.29 | $8.88 | 429 538 |
| 2022-06-06 | $8.85 | $8.97 | $8.24 | $8.42 | 632 939 |
| 2022-06-03 | $8.37 | $8.84 | $8.31 | $8.82 | 424 018 |
| 2022-06-02 | $8.32 | $8.53 | $8.20 | $8.41 | 358 576 |
| 2022-06-01 | $8.37 | $8.48 | $8.21 | $8.34 | 381 604 |
| 2022-05-31 | $8.21 | $8.51 | $8.04 | $8.32 | 588 920 |
| 2022-05-27 | $8.06 | $8.29 | $7.89 | $8.24 | 281 997 |
| 2022-05-26 | $8.14 | $8.14 | $7.77 | $8.01 | 620 289 |
| 2022-05-25 | $8.14 | $8.19 | $7.89 | $8.10 | 508 893 |
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
